Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Cohort Study: Insomnia linked to increased risk of recurrent cardiovascular events in patients with coronary heart disease.

12 Apr, 2022 | 08:36h | UTC

Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease – Sleep Advances

Commentary: Insomnia is linked with recurrent heart events in coronary patients – European Society of Cardiology

 

Acute phase of Kawasaki disease: a review of national guideline recommendations.

12 Apr, 2022 | 08:32h | UTC

Acute phase of Kawasaki disease: a review of national guideline recommendations – European Journal of Pediatrics

 

RCT: Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator?

12 Apr, 2022 | 08:23h | UTC

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial – Circulation

Commentary: Don’t Wait, Ablate to Prevent VT Episodes After an ICD Shock?— Early catheter ablation reduced deaths and ICD shocks in PARTITA trial – MedPage Today (free registration required)

 

Review | Secondary mitral regurgitation: when to refer, when to treat and how to treat?

12 Apr, 2022 | 08:15h | UTC

Secondary Mitral Regurgitation: When to Refer, When to Treat and How to Treat? – American College of Cardiology

Related:

ESC Position Statement: Management of secondary mitral regurgitation in patients with heart failure

Randomized Trial: Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Cohort study: Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure.

Meta-analysis: Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation

 

Review: Atrial fibrillation.

11 Apr, 2022 | 01:57h | UTC

Atrial fibrillation – Nature Reviews Disease Primers (if the link is paywalled, try this one)

Infographic: Atrial fibrillation – Nature Reviews Disease Primers (if the link is paywalled, try this one)

 

Commentary on Twitter

 

Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study.

11 Apr, 2022 | 01:48h | UTC

Twitter promotion is associated with higher citation rates of cardiovascular articles: the ESC Journals Randomized Study – European Society of Cardiology (link to abstract – $ for full-text)

Related:

Randomized Trial: Twitter Promotion Increases Citation Rates of Cardiovascular Articles

Does Tweeting Improve Citations? One-Year Results from the TSSMN Prospective Randomized Trial

A critical review on altmetrics: can we measure the social impact factor?

As scientists take to Twitter, study shows power of ‘visual abstract’ graphics

Riding the Twitter wave: Enthusiasm for the social media platform changed science communication during the pandemic—but will it last?

Optimizing the use of Twitter for research dissemination: The “Three Facts and a Story” randomized-controlled trial.

Perspective: How Twitter is Changing Medical Research

Keeping Up With Cardiology: Old-School Learning Versus the Twittersphere – TCTMD

Scientists on Twitter: Preaching to the choir or singing from the rooftops? – Facets

Rise of the Tweetorial – Precious Bodily Fluids

Social Medicine: Twitter in Healthcare – Journal of Clinical Medicine

University of Twitter? Scientists give impromptu lecture critiquing nutrition research – CBC

Twitter-Based Medicine: How Social Media is Changing the Public’s View of Medicine – The Health Care Blog

What’s your doctor reading? How social media is disrupting medical education – National Post

 

AHA Scientific Statement: addressing social determinants of health and mitigating health disparities across the lifespan in congenital heart disease.

11 Apr, 2022 | 01:31h | UTC

Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association – Circulation

Commentary: Social determinants of health affect care for people with congenital heart disease – American Heart Association

 

Large database with 10 registries or clinical trials finds valve-in-valve transcatheter aortic valve implantation (TAVI) resulted in similar mortality and stroke rates compared to native valve TAVI.

11 Apr, 2022 | 01:02h | UTC

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation – American Journal of Cardiology

 

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial.

11 Apr, 2022 | 00:50h | UTC

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial – European Heart Journal

Original Study: Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes

 

Commentary on Twitter (images under a https://creativecommons.org/licenses/by/4.0/ license)

 

M-A: Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome.

11 Apr, 2022 | 00:48h | UTC

Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis – BMJ Open

 

Commentary on Twitter

 

Review: Epigenetics in congenital heart disease.

8 Apr, 2022 | 10:12h | UTC

Epigenetics in Congenital Heart Disease – Journal of the American Heart Association

 

Study Commentary | Immediate versus delayed cardiac catheterization in post-arrest patients without ST elevation myocardial infarction: is survivorship bias an important influence?

8 Apr, 2022 | 10:11h | UTC

Immediate Versus Delayed Cardiac Catheterization in Post-Arrest Patients Without ST Elevation Myocardial Infarction: Is Survivorship Bias an Important Influence? – Annals of Emergency Medicine

Original Study: #ESCCongress – RCT: Immediate coronary angiography after out-of-hospital cardiac arrest without ST-segment elevation did not improve outcomes compared to delayed/selective angiography.

 

Current applications and limitations of European guidelines on blood pressure measurement: implications for clinical practice.

8 Apr, 2022 | 09:56h | UTC

Current applications and limitations of European guidelines on blood pressure measurement: implications for clinical practice – Internal and Emergency Medicine

Related:

Randomized Diagnostic Study: home blood pressure measurements correlate better with 24-h ambulatory monitoring measurements compared to clinic, and kiosk measurements.

Practice guidelines for office and out-of-office blood pressure measurement.

Study suggests a 30-second interval between automated office blood pressure measurements is as accurate and reliable as a 60-second interval.

USPSTF Statement recommends screening for hypertension in adults 18 years or older with office blood pressure measurement – diagnostic confirmation with blood pressure measurements outside of the clinical setting is advised before starting treatment

Study suggests that 7 days of home blood pressure monitoring is likely better than 24h ambulatory monitoring or 3 office measurements

 

Review: Myocardial inflammation and sudden death in the inherited cardiomyopathies.

8 Apr, 2022 | 09:46h | UTC

Myocardial Inflammation and Sudden Death in the Inherited Cardiomyopathies – Canadian Journal of Cardiology

 

Systematic Review: Approaches and outcomes of community health worker’s interventions for hypertension management and control in low-income and middle-income countries.

8 Apr, 2022 | 09:48h | UTC

Approaches and outcomes of community health worker’s interventions for hypertension management and control in low-income and middle-income countries: systematic review – BMJ Open

 

Randomized, sham-controlled trial: Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs.

7 Apr, 2022 | 09:49h | UTC

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary: Three-year trial of SPYRAL HTN-ON MED shows blood pressure reductions – MedicalXpress

Related:

Systematic Review: Renal denervation may have a modest effect in improving 24h ambulatory blood pressure monitoring (reduction in SBP by 5.29 mmHg and DBP by 3.75 mmHg) but does not improve major cardiovascular outcomes and renal function.

M-A: Renal denervation for hypertension is associated with a modest reduction in ambulatory blood pressure control (3.61 mm Hg reduction in ambulatory systolic BP and 1.85 mm Hg reduction in ambulatory diastolic BP).

#ACC21 – RCT: Among patients with resistant hypertension, ultrasound renal denervation resulted in a modest improvement in systolic BP (–4.5 mm Hg) vs. sham procedure.

Meta-Analysis: Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients with Hypertension

 

Commentary on Twitter

 

Cohort study and updated meta-analysis: greater dietary cholesterol and egg consumption linked to increased risk of overall and CVD mortality.

6 Apr, 2022 | 10:41h | UTC

Associations of Dietary Cholesterol, Serum Cholesterol, and Egg Consumption With Overall and Cause-Specific Mortality, and Systematic Review and Updated Meta-Analysis – Circulation

 

Review: Fulminant myocarditis in adults.

6 Apr, 2022 | 09:55h | UTC

Fulminant myocarditis in adults: a narrative review – Journal of Geriatric Cardiology

 

Review: Atrial fibrillation in older adults with cancer.

6 Apr, 2022 | 09:53h | UTC

Atrial fibrillation in older adults with cancer – Journal of Geriatric Cardiology

 

Registry-based cohort study: Trends in clinical practice and outcomes after percutaneous coronary intervention of unprotected left main coronary artery.

6 Apr, 2022 | 09:50h | UTC

Trends in Clinical Practice and Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery – Journal of the American Heart Association

Editorial: Is Percutaneous Coronary Intervention Now the Default Revascularization Strategy for Unprotected Left Main Coronary Artery Stenosis? – Journal of the American Heart Association

 

#ACC22 – RCT: In patients undergoing non-cardiac surgery, a strategy of aggressive intraoperative warming (target core temperature of 37°C) did not reduce major complications compared to routine thermal management (target of 35·5°C).

5 Apr, 2022 | 09:57h | UTC

Aggressive intraoperative warming versus routine thermal management during non-cardiac surgery (PROTECT): a multicentre, parallel group, superiority trial – The Lancet (free registration required)

Commentary: PROTECT: Aggressive Warming During Surgery Does Not Reduce Major Complications – American College of Cardiology

 

Seminar: Acute coronary syndromes.

5 Apr, 2022 | 09:48h | UTC

Acute coronary syndromes – The Lancet (free for a limited period)

 

Commentary on Twitter

https://twitter.com/TheLancet/status/1510213032143691776

 

Cohort study: Increased middle age serum sodium levels (may correlate with low water ingestion) are linked to increased risk of left ventricular hypertrophy and heart failure after 25 years of follow up.

5 Apr, 2022 | 09:44h | UTC

Middle age serum sodium levels in the upper part of normal range and risk of heart failure – European Heart journal (link to abstract – $ for full-text)

News Release: Good hydration may reduce long-term risks for heart failure – Serum sodium levels may help identify adults with a greater chance of experiencing heart disease. – National Institutes of Health

 

Cohort Study: Change in heart disease and stroke mortality before and during the Covid-19 pandemic.

5 Apr, 2022 | 08:47h | UTC

Age-Adjusted Mortality Rates and Age and Risk–Associated Contributions to Change in Heart Disease and Stroke Mortality, 2011-2019 and 2019-2020 – JAMA Network Open

Commentaries:

Several-Fold Increase in Stroke and Heart Disease Deaths During COVID-19 Pandemic – NeurologyToday

2019 to 2020 Saw Risk-Linked Deaths From Heart Disease, Stroke Up – HealthDay

 

Commentary from the author on Twitter (thread – click for more). Article and images under CC-BY License

 

#ACC22 – RCT: Edoxaban vs. dual antiplatelet therapy for preventing leaflet thrombosis and cerebral thromboembolism after TAVR.

5 Apr, 2022 | 08:45h | UTC

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial – Circulation

Commentary:

No reduction in stroke, mini strokes, blood clotting or changes in cognitive function with edoxaban after TAVR – American College of Cardiology

ADAPT-TAVR: Edoxaban vs. DAPT in Reducing SLT and Cerebral Thromboembolism After TAVR – American College of Cardiology

Related:

M-A: Single antiplatelet therapy should be used after transcatheter aortic valve implantation in patients without indication for anticoagulation.

M-A: Aspirin alone better than dual antiplatelet therapy after transcatheter aortic valve implantation

#ESCCongress – [Abstract Only] Randomized trial: aspirin with or without clopidogrel after transcatheter aortic-valve implantation

#ACC21 – [Not published yet] RCT: Among patients undergoing TAVR, full-dose apixaban is not superior to standard of care (vitamin K antagonist if indication for oral anticoagulation; antiplatelet therapy if no indication).

#AHA19 – [Abstract Only] Randomized Trial: An Antiplatelet-based Strategy is Associated with Better Outcomes vs. Anticoagulation After Transcatheter Aortic-Valve Replacement

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.